These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8575444)

  • 1. Effects of poliovirus 2A(pro) on vaccinia virus gene expression.
    Feduchi E; Aldabe R; Novoa I; Carrasco L
    Eur J Biochem; 1995 Dec; 234(3):849-54. PubMed ID: 8575444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of p220 by purified poliovirus 2A(pro) in cell-free systems: effects on translation of capped and uncapped mRNAs.
    Novoa I; Martínez-Abarca F; Fortes P; Ortín J; Carrasco L
    Biochemistry; 1997 Jun; 36(25):7802-9. PubMed ID: 9201923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of poliovirus 2Apro in mammalian cells: effects on translation.
    Aldabe R; Feduchi E; Novoa I; Carrasco L
    FEBS Lett; 1995 Dec; 377(1):1-5. PubMed ID: 8543008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus.
    Aldabe R; Feduchi E; Novoa I; Carrasco L
    Biochem Biophys Res Commun; 1995 Oct; 215(3):928-36. PubMed ID: 7488063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression.
    Barco A; Feduchi E; Carrasco L
    J Virol; 2000 Mar; 74(5):2383-92. PubMed ID: 10666269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.
    Lloyd RE; Grubman MJ; Ehrenfeld E
    J Virol; 1988 Nov; 62(11):4216-23. PubMed ID: 2845133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.
    Ventoso I; Carrasco L
    J Virol; 1995 Oct; 69(10):6280-8. PubMed ID: 7666528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
    Pal-Ghosh R; Morrow CD
    J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage.
    Irurzun A; Sánchez-Palomino S; Novoa I; Carrasco L
    J Virol; 1995 Dec; 69(12):7453-60. PubMed ID: 7494251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus protein synthesis has a low requirement for the intact translation initiation factor eIF4F, the cap-binding complex, within infected cells.
    Mulder J; Robertson ME; Seamons RA; Belsham GJ
    J Virol; 1998 Nov; 72(11):8813-9. PubMed ID: 9765426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.
    Kräusslich HG; Nicklin MJ; Toyoda H; Etchison D; Wimmer E
    J Virol; 1987 Sep; 61(9):2711-8. PubMed ID: 3039165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection.
    Pérez L; Carrasco L
    Virology; 1992 Jul; 189(1):178-86. PubMed ID: 1604809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.
    Turner PC; Young DC; Flanegan JB; Moyer RW
    Virology; 1989 Dec; 173(2):509-21. PubMed ID: 2556841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation.
    Sun XH; Baltimore D
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2143-6. PubMed ID: 2538833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.
    Wyckoff EE; Lloyd RE; Ehrenfeld E
    J Virol; 1992 May; 66(5):2943-51. PubMed ID: 1313911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.
    Wyckoff EE; Hershey JW; Ehrenfeld E
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9529-33. PubMed ID: 2175904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
    Jewell JE; Ball LA; Rueckert R
    J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of poliovirus 2Apro. Distinct inhibitory functions of 2apro on translation and transcription.
    Ventoso I; Barco A; Carrasco L
    J Biol Chem; 1998 Oct; 273(43):27960-7. PubMed ID: 9774410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease.
    Bovee ML; Marissen WE; Zamora M; Lloyd RE
    Virology; 1998 Jun; 245(2):229-40. PubMed ID: 9636362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.